Nephros
NEPH
17 hedge funds and large institutions have $7.33M invested in Nephros in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 2 closing their positions.
0.45% less ownership
Funds ownership: 41.1% → 40.65% (-0.45%)
11% less funds holding
Funds holding: 19 → 17 (-2)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
20% less capital invested
Capital invested by funds: $9.18M → $7.33M (-$1.85M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.8K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$14.3K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$10.7K |
| 4 |
EP
Elkhorn Partners
Omaha,
Nebraska
|
+$872 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$40 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$38K |
| 2 |
Renaissance Technologies
New York
|
-$32.7K |
| 3 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$29.5K |
| 4 |
IFG
Independent Financial Group
San Diego,
California
|
-$25.3K |
| 5 |
BA
Bard Associates
Chicago,
Illinois
|
-$6.38K |
NEPH Hedge Fund Activity: Q3 2024 in Review
17 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q3 2024, worth a combined $7.33M — down 20% from $9.18M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NEPH and 0 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 5 added.
The largest buyer was Vanguard Group, adding an estimated $15.8K. The largest seller was UBS Group, cutting an estimated $38K.
- 17 institutional investors held Nephros (NEPH) as of Q3 2024, down from 19 in Q2 2024.
- Funds reported $7.33M of Nephros stock for Q3 2024, down 20% quarter-over-quarter.
- 0 funds opened new Nephros positions in Q3 2024 and 2 closed out, a net change of -2 holders.
- The largest Nephros buyer in Q3 2024 was Vanguard Group, an estimated $15.8K added.
- The largest Nephros seller in Q3 2024 was UBS Group, an estimated $38K sold.
Based on aggregated 13F filings for Q3 2024.